295 related articles for article (PubMed ID: 8575837)
1. Characterization of an anti-CD44 single-chain FV antibody that stimulates natural killer cell activity and induces TNF alpha release.
Tan PH; Sandmaier BM; Stayton PS
Immunol Invest; 1995 Nov; 24(6):907-26. PubMed ID: 8575837
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family.
Cao P; Tang XM; Guan ZB; Diao ZY; Zhang SQ
Protein Expr Purif; 2005 Oct; 43(2):157-64. PubMed ID: 16023370
[TBL] [Abstract][Full Text] [Related]
3. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
Mallender WD; Carrero J; Voss EW
J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of natural killer activity by an antibody to CD44.
Tan PH; Santos EB; Rossbach HC; Sandmaier BM
J Immunol; 1993 Feb; 150(3):812-20. PubMed ID: 8423341
[TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of single-chain Fv antibody against human VEGF].
Wang D; Yang X; Yuan Q
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):526-9. PubMed ID: 11798812
[TBL] [Abstract][Full Text] [Related]
6. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
[TBL] [Abstract][Full Text] [Related]
7. Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths.
Shan D; Press OW; Tsu TT; Hayden MS; Ledbetter JA
J Immunol; 1999 Jun; 162(11):6589-95. PubMed ID: 10352275
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of recombinant single chain Fv antibody that recognizes platelet glycoprotein Ibalpha.
Dai K; Zhu H; Ruan C
Thromb Res; 2003 Jan; 109(2-3):137-44. PubMed ID: 12706643
[TBL] [Abstract][Full Text] [Related]
9. Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.
Sandmaier BM; Storb R; Bennett KL; Appelbaum FR; Santos EB
Blood; 1998 May; 91(9):3494-502. PubMed ID: 9558410
[TBL] [Abstract][Full Text] [Related]
10. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
[TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
Zhang M; Yu L; Huang H
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
Ruff-Jamison S; Glenney JR
Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
[TBL] [Abstract][Full Text] [Related]
13. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of enhancement of natural killer activity by an antibody to CD44: increase in conjugate formation and release of tumor necrosis factor alpha.
Tan PH; Liu Y; Santos EB; Sandmaier BM
Cell Immunol; 1995 Sep; 164(2):255-64. PubMed ID: 7544692
[TBL] [Abstract][Full Text] [Related]
15. A single chain Fv specific against Western equine encephalitis virus.
Xu B; Kriangkum J; Nagata LP; Fulton RE; Suresh MR
Hybridoma; 1999 Aug; 18(4):315-23. PubMed ID: 10571261
[TBL] [Abstract][Full Text] [Related]
16. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
17. Optimization of anti-tumor necrosis factor-alpha single chain Fv displayed on phages for creation of functional antibodies.
Mukai Y; Okamoto T; Kawamura M; Shibata H; Sugita T; Imai S; Abe Y; Nagano K; Nomura T; Kamada H; Tsutsumi Y; Mayumi T; Nakagawa S; Tsunoda S
Pharmazie; 2006 Oct; 61(10):889-90. PubMed ID: 17069432
[TBL] [Abstract][Full Text] [Related]
18. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
19. Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells.
Li J; Wang Y; Wang Z; Dong Z
Immunol Lett; 2000 Mar; 71(3):157-65. PubMed ID: 10722867
[TBL] [Abstract][Full Text] [Related]
20. Production and in vitro refolding of a single-chain antibody specific for human plasma apolipoprotein A-I.
Cho WK; Sohn U; Kwak JW
J Biotechnol; 2000 Feb; 77(2-3):169-78. PubMed ID: 10682277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
